Literature DB >> 31650748

[Modified staging strategy in treatment of type C3 Pilon fractures].

Yu Chen1, Hui Zhang2, Xi Liu1, Yaxing Li1, Boquan Qin1, Yi Ren1, Shizhou Wu1, Fuguo Huang1.   

Abstract

OBJECTIVE: To investigate the safety, feasibility, and effectiveness of modified staging strategy in treatment of type C3 Pilon fractures.
METHODS: The clinical data of 23 patients with type C3 Pilon fractures treated with modified staging strategy between January 2012 and January 2018 was retrospectively analyzed. There were 14 males and 9 females with an average age of 47.9 years (range, 22-61 years). Twenty-three cases were high-energy injuries, including 11 cases of traffic accidents and 12 cases of falling from height. One case was an open fracture of Gustilo type ⅢA with no obvious sign of infection on the wound after early treatment. The remaining patients were closed fractures. The time from injury to admission was 3-40 hours with an average of 16.4 hours. The preoperative pain visual analogue scale (VAS) score was 7.22±1.17 and American Orthopaedic Foot and Ankle Society (AOFAS) score was 0. The flexion and plantar flexion activities of ankle joint were (1.13±0.26) and (4.79±0.93)°, respectively. Twenty-two patients had a tibiofibular fracture. In the first-stage operation, the posterior approach was used to reduce the posterior column fracture and the external stent was temporarily assisted. After the soft tissue crisis was removed, the final fracture reduction and internal fixation was performed through the anterior approach in the second-stage operation.
RESULTS: All 23 patients were followed up 12-84 months with an average of 26.6 months. The waiting time before the first-stage operation was 4-47 hours with an average of 23.4 hours. The interval between the two stage operations was 6-11 days with an average of 7.9 days. The first-stage operation time was 60-90 minutes with an average of 67.8 minutes; the second-stage operation time was 110-160 minutes with an average of 124.1 minutes. The hospital stay was 15-28 days with an average of 23.5 days. One patient (4.35%) had a tourniquet paralysis symptom after the second-stage operation, and two patients (8.7%) had delayed anterior incision healing. The other patients had incision healing without early complications. The radiographic review showed that the quality of articular surface reduction was excellent in 19 cases, good in 2 cases, and poor in 2 cases, with an excellent and good rate of 91.3%. At last follow-up, the fractures healed with no bone nonunion and malunion; the different degrees of osteoarthritis occurred in 7 cases. At last follow-up, the VAS score was 0.89 ±0.88 and the AOFAS score was 81.3±7.8. The flexion and plantar flexion activities of ankle joint were (10.23±5.05) and (20.97±3.92)°, respectively, and the differences between pre- and post-operation were significant ( P<0.05).
CONCLUSION: The midified staging strategy can not only provide a template for articular surface reduction for the second-stage anterior surgery, but also improve the quality of the reduction. It can also reduce the interval between the two operations and the operation time of the second-stage operation through the first-stage posterior fascial decompression, and can obtain satisfactory effectiveness.

Entities:  

Keywords:  Type C3 Pilon fracture; internal fixation; open reduction; staging operation

Mesh:

Year:  2019        PMID: 31650748      PMCID: PMC8337458          DOI: 10.7507/1002-1892.201903100

Source DB:  PubMed          Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi        ISSN: 1002-1892


  21 in total

Review 1.  Tibial pilon fractures: a review of incidence, diagnosis, treatment, and complications.

Authors:  Cyril Mauffrey; Gabriel Vasario; Bruno Battiston; Charlie Lewis; James Beazley; David Seligson
Journal:  Acta Orthop Belg       Date:  2011-08       Impact factor: 0.500

Review 2.  A Meta-Analysis for Postoperative Complications in Tibial Plafond Fracture: Open Reduction and Internal Fixation Versus Limited Internal Fixation Combined With External Fixator.

Authors:  Dong Wang; Jian-Ping Xiang; Xiao-Hu Chen; Qing-Tang Zhu
Journal:  J Foot Ankle Surg       Date:  2014-08-12       Impact factor: 1.286

Review 3.  Pilon Fracture: Preventing Complications.

Authors:  Stephen A Kottmeier; Randall Drew Madison; Nicholas Divaris
Journal:  J Am Acad Orthop Surg       Date:  2018-09-15       Impact factor: 3.020

4.  Type C tibial pilon fractures: short- and long-term outcome following operative intervention.

Authors:  A D Duckworth; J G Jefferies; N D Clement; T O White
Journal:  Bone Joint J       Date:  2016-08       Impact factor: 5.082

5.  Two-staged delayed open reduction and internal fixation of severe pilon fractures.

Authors:  M J Patterson; J D Cole
Journal:  J Orthop Trauma       Date:  1999-02       Impact factor: 2.512

6.  [IMPROVED DOUBLE OPERATIVE APPROACHES FOR TREATMENT OF Pilon FRACTURES ACCOMPANIED WITH FIBULA FRACTURES].

Authors:  Mingxin Wang; Dechang Liu; Kun Wang; Deqiang Meng; Yue Ding
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2016-12-08

7.  Does a Staged Posterior Approach Have a Negative Effect on OTA 43C Fracture Outcomes?

Authors:  Daniel S Chan; Paul M Balthrop; Brian White; David Glassman; Roy W Sanders
Journal:  J Orthop Trauma       Date:  2017-02       Impact factor: 2.512

8.  Axial computed tomography of pilon fractures.

Authors:  P Tornetta; J Gorup
Journal:  Clin Orthop Relat Res       Date:  1996-02       Impact factor: 4.176

9.  A staged protocol for soft tissue management in the treatment of complex pilon fractures.

Authors:  Michael Sirkin; Roy Sanders; Thomas DiPasquale; Dolfi Herscovici
Journal:  J Orthop Trauma       Date:  2004-09       Impact factor: 2.512

10.  Two-stage open reduction and internal fixation versus limited internal fixation combined with external fixation: a meta-analysis of postoperative complications in patients with severe Pilon fractures.

Authors:  Xueliang Cui; Hui Chen; Yunfeng Rui; Yang Niu; He Li
Journal:  J Int Med Res       Date:  2018-06-19       Impact factor: 1.671

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.